Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3

Journal of the National Cancer Institute

Volumn 104, Issue 22, 2012, Pages 1738-1749

  Wentzensen, Nicolas ^a   Sun, Chang ^b,c   Ghosh, Arpita ^a   Kinney, Walter ^d   Mirabello, Lisa ^a   Wacholder, Sholom ^a   Shaber, Ruth ^e   Lamere, Brandon ^f   Clarke, Megan ^a   Lorincz, Attila T ^g   Castle, Philip E ^h   Schiffman, Mark ^a   Burk, Robert D ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c YUNNAN UNIVERSITY   (China)

^d KAISER PERMANENTE   (United States)

^e Care Management Institute   (United States)

^f DIVISION OF RESEARCH   (United States)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^h American Society of Clinical Pathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CPG ISLAND; DNA METHYLATION; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 45; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PHYLOGENETIC TREE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS GENE;

ADULT; ALPHAPAPILLOMAVIRUS; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA METHYLATION; DNA, VIRAL; FEMALE; GENOME, VIRAL; GENOTYPE; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS 31; HUMANS; LOGISTIC MODELS; MIDDLE AGED; NEOPLASM GRADING; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; SAMPLE SIZE; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84870170478     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs425     Document Type: Article

References (24)

1. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890-907. (Pubitemid 47371147)
2. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011;103(5):368-383.
3. McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9(5):425-434.
4. Doorbar J. Papillomavirus life cycle organization and biomarker selection. Dis Markers. 2007;23(4):297-313. (Pubitemid 47015790)
5. Wentzensen N, von Knebel DM. Biomarkers in cervical cancer screening. Dis Markers. 2007;23(4):315-330. (Pubitemid 47015791)
6. Mirabello L, Sun C, Ghosh A, Rodriguez AC, Schiffman M, Wentzensen N, et al. Methylation of the HPV16 genome is associated with disease progression in a prospective population-based cohort. J Natl Cancer Inst. 2012;104:556-565.
7. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type, and year of publication. Int J Cancer. 2011;128(4):927-935.
8. Castle PE, Shaber R, LaMere BJ, Kinney W, Fetterma B, Poitras N et al. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California. Cancer Epidemiol Biomarkers Prev. 2011;20(5):946-953.
9. Castle PE, Schiffman M, Gravitt PE, Kendall H, Fishman S, Dong H, et al. Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol. 2002;68(3):417-423.
10. Sun C, Reimers LL, Burk RD. Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. Gynecol Oncol. 2011;121(1): 59-63.
11. Chen Z, Desalle R, Schiffman M, Herrero R, Burk RD. Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97. J Virol. 2009;83(3):1443-1455.
12. Vinokurova S, Wentzensen N, Kraus I, Klaes R, Driesch C, Melsheimer P, et al. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res. 2008;68(1):307-313. (Pubitemid 351380133)
13. Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, et al. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLOS ONE. 2011;6(5):e20183.
14. Curradi M, Izzo A, Badaracco G, Landsberger N. Molecular mechanisms of gene silencing mediated by DNA methylation. Mol Cell Biol. 2002;22(9):3157-3173. (Pubitemid 34437474)
15. Wentzensen N, Sherman ME, Schiffman M, Wang SS. Utility of methylation markers in cervical cancer early detection: appraisal of the state-ofthe- science. Gynecol Oncol. 2009;112(2):293-299.
16. Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA, et al. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer. 2009;125(9):2151-2158.
17. Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 2007;370(9601):1764-1772. (Pubitemid 350137476)
18. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357(16): 1579-1588. (Pubitemid 47598400)
19. Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007;357(16):1589-1597. (Pubitemid 47598401)
20. Badal S, Badal V, Calleja-Macias IE, Kalantari M, Chuang LS, Li BF, et al. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology. 2004;324(2):483-492. (Pubitemid 38797864)
21. Fernandez AF, Rosales C, Lopez-Nieva P, Grana O, Ballestar E, Ropero S, et al. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res. 2009;19(3):438-451.
22. Turan T, Kalantari M, Calleja-Macias IE, Cubie HA, Cuschieri K, Villa LL, et al. Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression? Virology. 2006;349(1):175-183.
23. Ding DC, Chiang MH, Lai HC, Hsiung CA, Hsieh CY, Chu TY. Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia. Eur J Obstet Gynecol Reprod Biol. 2009;147(2):215-220.
24. Xi LF, Jiang M, Shen Z, Hulbert A, Zhou XH, Lin YY, et al. Inverse association between methylation of human papillomavirus type 16 DNA and risk of cervical intraepithelial neoplasia grades 2 or 3. PLOS ONE. 2011;6(8):e23897.